IFCC Information Guide on COVID-19
The IFCC is pleased to publish an online resource providing key information on laboratory guidelines, biosafety, and other important resources to assist member societies around the world and their clinical laboratories as they face the challenges posed by the COVID-19 outbreak.
The IFCC Information Guide on COVID-19 is continuously updated
-
Initially Published: 23 March, 2020
-
Current version: 23 December, 2021 updates
A Summary of the Guide in Spanish and Czech is also available
-
Click aquí para descargar el Resumen traducido de la Guía de Información de la IFCC sobre COVID-19
-
Kliknutím zde stáhnete českou verzi IFCC informačního souhrnu o COVID 19 z 16 . dubna 2020
Introduction
Coronavirus disease 2019, abbreviated to COVID-19, is an emerging global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the number of individuals infected with COVID-19 continues to rise globally and healthcare systems become increasingly stressed, it is clear that the clinical laboratory will play an essential role in this crisis, contributing to patient screening, diagnosis, monitoring/treatment, as well as epidemiologic recovery/surveillance. This guide aims to organize relevant available information on laboratory screening, testing protocols, diagnosis, and other general information on COVID-19 for laboratory professionals, including links to helpful resources and interim guidelines. It will be continually updated as new guidelines and literature become available.
Click on left side menu and access the different sections.
Table of Contents:
Introduction
4. Biosafety Guidelines for the Clinical Laboratory
5. Biochemical Monitoring of COVID-19 Patients
Coordinators - IFCC COVID-19 Guide:
Mary Kathryn Bohn & Khosrow Adeli
University of Toronto, Toronto, ON, Canada
Questions:
Please direct questions to Silvia Colli-Lanzi in the IFCC Office: colli-lanzi@ifcc.org